Merck: Smart Value For Potentially Strong Total Returns
Seeking Alpha,
Follow Summary Merck remains undervalued with a strong set of growing drugs and new indications in its pipeline.
Follow Summary Merck remains undervalued with a strong set of growing drugs and new indications in its pipeline.
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple…
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple…
Halozyme (HALO) has something many drugmakers need — and that paradigm is showing up as HALO stock approaches another record…